Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study

PURPOSE: We aimed to evaluate the long-term survival outcomes of concurrent chemoradiotherapy (CCRT) combined with nimotuzumab followed by surgery in patients with locally advanced cervical cancer (LACC). PATIENTS AND METHODS: Patients received whole pelvic intensity-modulated radiation therapy (IMR...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Defeng, Wu, Yuying, Liu, Xu, Jiang, Hailan, Zhu, Chaohua, Liu, Pei, Dang, Junming, Li, Xianglong, Chen, Zhaohong, Long, Xianfeng, Pang, Qiang, Peng, Luxing, Deng, Shan, Gu, Junzhao, Zhao, Renfeng, Chen, Changyi, Lu, Heming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718864/
https://www.ncbi.nlm.nih.gov/pubmed/33293859
http://dx.doi.org/10.2147/CMAR.S282372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718864/
https://www.ncbi.nlm.nih.gov/pubmed/33293859
http://dx.doi.org/10.2147/CMAR.S282372

Ejemplares similares